Valartin Pharma

Valartin Pharma is a prominent Ukrainian pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality medicinal products. The company is a recognized leader in the Ukrainian market for the treatment of viral Hepatitis C, offering a range of direct-acting antivirals through both proprietary production and strategic international partnerships. Beyond hepatology, Valartin Pharma maintains a diverse portfolio in cardiology, gastroenterology, and respiratory health, including the well-known adsorbent brand Sorbex. Their manufacturing facilities are certified according to international Good Manufacturing Practice (GMP) standards, ensuring high quality for domestic and export markets. The company plays a critical role in public health initiatives in Ukraine, particularly in expanding access to essential therapies for infectious diseases.